Advisors Preferred LLC Buys New Stake in Globe Life Inc. $GL

Advisors Preferred LLC acquired a new stake in Globe Life Inc. (NYSE:GL) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 3,746 shares of the company’s stock, valued at approximately $521,000.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Hillsdale Investment Management Inc. increased its position in shares of Globe Life by 17.9% in the 1st quarter. Hillsdale Investment Management Inc. now owns 10,550 shares of the company’s stock valued at $1,468,000 after purchasing an additional 1,600 shares during the last quarter. Principal Financial Group Inc. grew its stake in shares of Globe Life by 9.9% during the first quarter. Principal Financial Group Inc. now owns 108,640 shares of the company’s stock worth $15,119,000 after purchasing an additional 9,761 shares in the last quarter. Chicago Partners Investment Group LLC increased its holdings in Globe Life by 35.4% in the first quarter. Chicago Partners Investment Group LLC now owns 4,552 shares of the company’s stock valued at $689,000 after buying an additional 1,189 shares during the last quarter. Arbejdsmarkedets Tillaegspension increased its holdings in Globe Life by 4.6% in the first quarter. Arbejdsmarkedets Tillaegspension now owns 182,830 shares of the company’s stock valued at $25,444,000 after buying an additional 8,069 shares during the last quarter. Finally, Teachers Retirement System of The State of Kentucky raised its stake in Globe Life by 4.2% in the first quarter. Teachers Retirement System of The State of Kentucky now owns 189,815 shares of the company’s stock valued at $26,417,000 after buying an additional 7,600 shares in the last quarter. 81.61% of the stock is currently owned by hedge funds and other institutional investors.

Globe Life Trading Up 1.4%

NYSE:GL opened at $181.54 on Thursday. Globe Life Inc. has a 12-month low of $117.96 and a 12-month high of $182.32. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.38. The stock’s 50 day simple moving average is $165.24 and its 200-day simple moving average is $151.01. The firm has a market cap of $14.10 billion, a P/E ratio of 12.55 and a beta of 0.47.

Globe Life (NYSE:GL) last issued its quarterly earnings results on Wednesday, April 22nd. The company reported $3.43 earnings per share for the quarter, missing the consensus estimate of $3.46 by ($0.03). The company had revenue of $1.56 billion for the quarter, compared to analyst estimates of $1.56 billion. Globe Life had a return on equity of 20.94% and a net margin of 19.38%.Globe Life’s revenue for the quarter was up 5.3% compared to the same quarter last year. During the same period in the prior year, the business earned $3.07 earnings per share. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. Equities analysts anticipate that Globe Life Inc. will post 15.64 EPS for the current year.

Globe Life Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Monday, July 6th will be given a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a dividend yield of 0.7%. The ex-dividend date is Monday, July 6th. Globe Life’s payout ratio is presently 9.13%.

Analyst Upgrades and Downgrades

GL has been the subject of a number of recent analyst reports. Truist Financial lifted their price target on Globe Life from $180.00 to $185.00 and gave the stock a “buy” rating in a report on Friday, April 24th. Jefferies Financial Group raised their target price on Globe Life from $147.00 to $166.00 and gave the stock a “hold” rating in a research report on Friday, July 10th. Keefe, Bruyette & Woods boosted their target price on Globe Life from $180.00 to $192.00 and gave the stock an “outperform” rating in a research note on Monday. Morgan Stanley upped their price target on Globe Life from $181.00 to $208.00 and gave the company an “overweight” rating in a report on Monday, July 6th. Finally, Piper Sandler increased their target price on shares of Globe Life from $175.00 to $200.00 and gave the company an “overweight” rating in a research report on Wednesday. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, Globe Life presently has an average rating of “Moderate Buy” and an average price target of $184.60.

Insider Buying and Selling at Globe Life

In other news, Director Cheryl Alston sold 8,258 shares of the stock in a transaction dated Thursday, June 25th. The shares were sold at an average price of $179.24, for a total value of $1,480,163.92. Following the completion of the transaction, the director owned 16,621 shares in the company, valued at $2,979,148.04. This trade represents a 33.19% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Frank M. Svoboda sold 20,000 shares of the business’s stock in a transaction dated Friday, May 22nd. The stock was sold at an average price of $156.68, for a total transaction of $3,133,600.00. Following the sale, the chief executive officer directly owned 54,020 shares in the company, valued at approximately $8,463,853.60. This represents a 27.02% decrease in their position. The SEC filing for this sale provides additional information. Over the last 90 days, insiders sold 124,187 shares of company stock worth $19,529,414. Company insiders own 2.11% of the company’s stock.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.